J. Annema (Amsterdam, Netherlands), M. Tamm (Basel, Switzerland)
Targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 crossover patient outcomes.
P. Shah (London, United Kingdom), A. Valipour (Vienna, Austria), C. Pison (Grenoble, France), C. Schumann (Kempten, Germany), P. Bonta (Amsterdam, Netherlands), R. Kessler (Strasborg, France), W. Gesierich (München, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), D. Skowasch (Bonn, Germany), D. Slebos (Groningen, Netherlands)
|     |
Pre-treatment lung function decline stabilizes up to 3 year after targeted lung denervation in COPD
J. Hartman (Groningen, Netherlands), S. Augustijn (Groningen, Netherlands), K. Klooster (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), D. Slebos (Groningen, Netherlands)
| |
Impact of endoscopic valve therapy on hypercapnia in patients with chronic hypercapnic failure based on a severe lung emphysema
M. Rötting (Heidelberg, Germany), M. Polke (Heidelberg, Germany), K. Kriegsmann (Heidelberg, Germany), N. Sarmand (Heidelberg, Germany), R. Eberhardt (Heidelberg, Germany), F. Herth (Heidelberg, Germany), D. Gompelmann (Heidelberg, Germany)
| |
Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients
P. Lenga (Berlin, Germany), C. Grah (Berlin, Germany), C. Ruwwe-Glösenkamp (Berlin, Germany), J. Rückert (Berlin, Germany), J. Pfannschmidt (Berlin, Germany), S. Eggeling (Berlin, Germany), S. Kurz (Berlin, Germany), G. Leschber (Berlin, Germany), B. Schmidt (Berlin, Germany), P. Schneider (Berlin, Germany), A. Gebhardt (Berlin, Germany), B. Becke (Brandenburg, Germany), R. Hübner (Berlin, Germany)
| |
Value of Transbronchial Lung Cryobiopsy in Patients Suspicious of Peripheral Lung Cancer
F. Herth (Heidelberg, Germany), J. Sun (Shanghai, China), M. Mayer (Heidelberggghai, Germany), J. Herth (HeidelbergShanghai, Germany), R. Eberhardt (Shanghai, Germany), K. Jkontogianni (Shanghai, Germany), L. Yarmus (Baltimore, United States of America)
| |
Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases.
S. Tomassetti (Firenze, Italy), M. Pavone (Catania, Italy), C. Ravaglia (Forlì, Italy), A. Wells (London, United Kingdom), C. Vancheri (Catania, Italy), E. Rosi (Firenze, Italy), A. Cavazza (Reggio Emilia, Italy), T. Colby (Scottsdale, United States of America), G. Rossi (Ravenna, Italy), J. Ryu (Rochester, United States of America), S. Puglisi (Forlì, Italy), A. Arcadu (Forlì, Italy), A. Dubini (Forlì, Italy), S. Piciucchi (Frolì, Italy), F. Lavorini (Firenze, Italy), V. Poletti (Forlì, Italy)
| |